Elisabeth Vinner
university of lille
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Elisabeth Vinner.
Therapeutic Drug Monitoring | 2003
Elisabeth Vinner; Jean Vignau; Denise Thibault; Xavier Codaccioni; Claudie Brassart; Luc Humbert; Michel Lhermitte
&NA; Recently, interest in hair analysis in such fields as drug abuse, driving, or for clinical purposes (determination of drug‐exposed neonates especially) has grown because of the highly sensitive method of detection (GC‐MS) that can now be applied. Neonates born to drug‐addicted mothers can suffer from neonatal withdrawal syndrome (NWS), which requires morphine treatment in its severe forms. To assess and measure toxicologic factors predicting the appearance and the severity of this syndrome, matrices such as urine, meconium, and hair are necessary. Cannabinoids, opiates, cocaine (and its metabolites), and methadone in particular were determined in the various matrices collected in 17 mother/neonate pairs. An immunologic screening method was used, and quantification was achieved with GC‐MS. In spite of some bias (color, length, race) that might hinder an accurate interpretation, the results of hair analysis makes it possible to confirm a fetal drug exposure and to reinforce the diagnosis of the NWS observed, particularly when results obtained in other matrices are negative. Hair analysis contributes to our ability to predict a NWS.
Forensic Science International | 2003
Elisabeth Vinner; Jean Vignau; Denise Thibault; Xavier Codaccioni; Claudie Brassart; Luc Humbert; Michel Lhermitte
The increasing interest in toxicological hair analysis as a marker of human exposure to xenobiotics such as illicit substances or therapeutic drugs, has been made feasible by the extension of mass spectrometry, a highly sensitive method of detection. A newborn exposed to drugs in utero can suffer from a varying degree of withdrawal syndrome, a few days after birth. If of opiate origin, the withdrawal syndrome can be treated with morphine, among other therapeutics, but it is not easy to diagnose because of atypical symptoms presented by neonates and especially when maternal drug addiction has not been revealed. To assess and measure toxicological factors linked with the appearance and the severity of this syndrome, maternal and neonatal matrices such as urine, meconium and hair were collected during a protocol approved by the ethical committee. Opiates in particular were measured with GC-MS and potential combined dependences (cannabis, cocaine, amphetamine, LSD and benzodiazepines) and/or substitutive therapeutics (methadone or buprenorphine) were also assessed in 17 mother/neonate couples. Gestational opiate exposure profiles were drawn up and linked with the observed withdrawal syndromes. A withdrawal syndrome seems to appear more frequently after foetal exposure to an association of opiates/substitutive molecules (8 out of 10 withdrawal syndromes observed in this study), although the impact of cocaine and benzodiazepines must also be taken into account. The results obtained in neonatal hair make it possible to affirm foetal drug exposure and are in accordance, for the majority, with the appearance of a neonatal withdrawal syndrome (NWS). Neonatal hair analysis could contribute to assess in utero exposure to opiates, particularly when results in urine and meconium are negative or when these matrices are not available.
European Journal of Neuroscience | 2006
Vincent Van Waes; Mihaela Enache; Isabelle Dutriez; Jean Lesage; Sara Morley-Fletcher; Elisabeth Vinner; Michel Lhermitte; Didier Vieau; Stefania Maccari; Muriel Darnaudéry
The period of adolescence and environmental factors, such as stress, are important in determining ethanol vulnerability in both humans and rats. Ethanol is a powerful activator of the hypothalamic‐pituitary‐adrenal (HPA) axis but attenuated responses of the HPA axis to ethanol have been described in populations with a high risk of ethanol abuse. In rats, prenatal stress leads to prolonged stress‐induced corticosterone secretion and increases the vulnerability to drugs of abuse, such as amphetamine and nicotine in adulthood and 3,4‐methylenedioxymethamphetamine in adolescent rats. The aim of the present study was to assess the impact of a prenatal stress on HPA axis responsiveness to a moderate dose of ethanol (1.5 g/kg i.p.) in adolescent male rats (28 days old). The parameters evaluated were plasma adrenocorticotropic hormone, plasma corticosterone and mRNA expression of HPA axis central markers (mineralocorticoid receptor, glucocorticoid receptor, corticotropin‐releasing hormone and pro‐opiomelanocortin). Contrary to prior expectations, our results demonstrate that prenatal stress blunts the HPA axis responsiveness to a moderate dose of ethanol in adolescent rats in spite of similar blood ethanol levels. These data suggest that prenatal stress may have the opposite effect on the response to stress depending on the attributes of the stressor stimulus. They thus raise questions about the possible impact of prenatal stress on the further development of ethanol vulnerability.
Biomedical Chromatography | 1999
Betty Dehon; Jean-Luc Chagnon; Elisabeth Vinner; Jean Pommery; Daniel Mathieu; Michel Lhermitte
A case involving a suicide by the ingestion of colchicine tablets is presented. Liquid chromatography has been used to measure the drug level in blood and in post-mortem tissues of the patient (a 42-year-old man). Plasma concentration 24 h after ingestion was 4.5 ng/mL. On autopsy, the kidney showed the highest concentration (396 ng/g). High concentrations were also found in the liver (347 ng/g) and heart (334 ng/g). Low concentrations were detected in the lung (58 ng/g), muscle (10 ng/g) and brain (5 ng/g).
Alcoholism: Clinical and Experimental Research | 2009
Vincent Van Waes; Mihaela Enache; Annarita Zuena; Jérôme Mairesse; Ferdinando Nicoletti; Elisabeth Vinner; Michel Lhermitte; Stefania Maccari; Muriel Darnaudéry
BACKGROUND Although it is generally believed that chronic ethanol consumption impairs learning and memory, results obtained in experimental animals are not univocal, and there are conditions in which ethanol paradoxically improves cognitive functions. In the present work, we investigated the effects of prenatal stress and of chronic ethanol exposure during adulthood on spatial memory in rats. METHODS Rats were subjected to a prenatal stress delivered as 3 daily 45-minute sections of restraint stress to the mothers during the last 10 days of pregnancy (PRS rats). After 7 months of ethanol exposure (ethanol 10%, oral intake), memory performances were evaluated in a spatial discrimination test in control and PRS male rats. Then, the oxidative damages and the expression of metabotropic glutamate (mGlu) receptors were assessed in their hippocampus. RESULTS Chronic ethanol exposure resulted in a reduced performance in a spatial recognition task in control animals. Unexpectedly, however, the same treatment attenuated spatial memory deficits in rats that had been subjected to prenatal stress. This paradigm of ethanol administration did not produce detectable signs of oxidative damage in the hippocampus in either unstressed or PRS rats. Interestingly, ethanol intake resulted in differential effects in the expression of mGlu receptor subtypes implicated in mechanisms of learning and memory. In control rats, ethanol intake reduced mGlu2/3 and mGlu5 receptor levels in the hippocampus; in PRS rats, which exhibited a constitutive reduction in the levels of these mGlu receptor subtypes, ethanol increased the expression of mGlu1a receptors but did not change the expression of mGlu2/3 or mGlu5 receptors. CONCLUSION Our findings support the idea that stress-related events occurring before birth have long-lasting effects on brain function and behavior, and suggest that the impact of ethanol on cognition is not only dose- and duration-dependent, but also critically influenced by early life experiences.
Biomedical Chromatography | 2001
Elisabeth Vinner; M. Stievenart; L. Humbert; Daniel Mathieu; Michel Lhermitte
Psychopharmacology | 2011
Vincent Van Waes; Mihaela Enache; Olivier Berton; Elisabeth Vinner; Michel Lhermitte; Stefania Maccari; Muriel Darnaudéry
Annales De Toxicologie Analytique | 2005
Bernard Dingeon; Marie-Françoise Dreyfuss; Yvan Gaillard; Anne Le Bouil; Michel Lhermitte; Stéphanie Mazzega; Mustapha Moulsma; Gilbert Pépin; Martine Perrin; Jocelyne Plesse; Olivier Roussel; Marie-Thérèse Thevenot; Elisabeth Vinner; Marc Deveaux
Journal of Analytical Toxicology | 2007
F. Klinzig; Elisabeth Vinner; C. Brassart; E. Houdain; Luc Humbert; Michel Lhermitte
Journal of Analytical Toxicology | 2006
Bernard Cartigny; Nathalie Azaroual; Christophe Bochu; Elisabeth Vinner; Michel Imbenotte; Gaston Vermeersch; Michel Lhermitte